238 related articles for article (PubMed ID: 21882946)
21. Reprogramming with defined factors: from induced pluripotency to induced transdifferentiation.
Masip M; Veiga A; Izpisúa Belmonte JC; Simón C
Mol Hum Reprod; 2010 Nov; 16(11):856-68. PubMed ID: 20616150
[TBL] [Abstract][Full Text] [Related]
22. Identification and characterization of small-molecule ligands that maintain pluripotency of human embryonic stem cells.
Burton P; Adams DR; Abraham A; Allcock RW; Jiang Z; McCahill A; Gilmour J; McAbney J; Kane NM; Baillie GS; McKenzie FR; Baker AH; Houslay MD; Mountford JC; Milligan G
Biochem Soc Trans; 2010 Aug; 38(4):1058-61. PubMed ID: 20659003
[TBL] [Abstract][Full Text] [Related]
23. Impacts of recent advances in cardiovascular regenerative medicine on clinical therapies and drug discovery.
Murata M; Tohyama S; Fukuda K
Pharmacol Ther; 2010 May; 126(2):109-18. PubMed ID: 20156482
[TBL] [Abstract][Full Text] [Related]
24. Nuclear reprogramming and pluripotency of embryonic cells: Application to the isolation of embryonic stem cells in farm animals.
Renard JP; Maruotti J; Jouneau A; Vignon X
Theriogenology; 2007 Sep; 68 Suppl 1():S196-205. PubMed ID: 17610945
[TBL] [Abstract][Full Text] [Related]
25. The use of signalling pathway inhibitors and chromatin modifiers for enhancing pluripotency.
Sumer H; Liu J; Verma PJ
Theriogenology; 2010 Sep; 74(4):525-33. PubMed ID: 20615537
[TBL] [Abstract][Full Text] [Related]
26. Equine embryos and embryonic stem cells: defining reliable markers of pluripotency.
Paris DB; Stout TA
Theriogenology; 2010 Sep; 74(4):516-24. PubMed ID: 20071015
[TBL] [Abstract][Full Text] [Related]
27. Human stem cells for modeling neurological disorders: accelerating the drug discovery pipeline.
Crook JM; Kobayashi NR
J Cell Biochem; 2008 Dec; 105(6):1361-6. PubMed ID: 18980214
[TBL] [Abstract][Full Text] [Related]
28. A potential role for insulin-like growth factor signaling in induction of pluripotent stem cell formation.
Li Y; Geng YJ
Growth Horm IGF Res; 2010 Dec; 20(6):391-8. PubMed ID: 20956084
[TBL] [Abstract][Full Text] [Related]
29. Directed differentiation of pluripotent stem cells: from developmental biology to therapeutic applications.
Irion S; Nostro MC; Kattman SJ; Keller GM
Cold Spring Harb Symp Quant Biol; 2008; 73():101-10. PubMed ID: 19329573
[TBL] [Abstract][Full Text] [Related]
30. Proteomic analysis of membrane proteins expressed specifically in pluripotent murine embryonic stem cells.
Intoh A; Kurisaki A; Yamanaka Y; Hirano H; Fukuda H; Sugino H; Asashima M
Proteomics; 2009 Jan; 9(1):126-37. PubMed ID: 19053146
[TBL] [Abstract][Full Text] [Related]
31. Natural and artificial routes to pluripotency.
Krueger WH; Swanson LC; Tanasijevic B; Rasmussen TP
Int J Dev Biol; 2010; 54(11-12):1545-64. PubMed ID: 21404178
[TBL] [Abstract][Full Text] [Related]
32. More synergetic cooperation of Yamanaka factors in induced pluripotent stem cells than in embryonic stem cells.
Huang J; Chen T; Liu X; Jiang J; Li J; Li D; Liu XS; Li W; Kang J; Pei G
Cell Res; 2009 Oct; 19(10):1127-38. PubMed ID: 19736564
[TBL] [Abstract][Full Text] [Related]
33. Small molecules targeting in vivo tissue regeneration.
Längle D; Halver J; Rathmer B; Willems E; Schade D
ACS Chem Biol; 2014 Jan; 9(1):57-71. PubMed ID: 24372447
[TBL] [Abstract][Full Text] [Related]
34. Exploiting pluripotency for therapeutic gain.
Deng W
Panminerva Med; 2010 Jun; 52(2):167-73. PubMed ID: 20517198
[TBL] [Abstract][Full Text] [Related]
35. An introduction to induced pluripotent stem cells.
Hanley J; Rastegarlari G; Nathwani AC
Br J Haematol; 2010 Oct; 151(1):16-24. PubMed ID: 20666774
[TBL] [Abstract][Full Text] [Related]
36. [Induced pluripotent stem cells generated from reprogramming differentiated cells by defined factors].
Xia X; Chu J; Chen X
Sheng Wu Gong Cheng Xue Bao; 2008 Jul; 24(7):1121-7. PubMed ID: 18837383
[TBL] [Abstract][Full Text] [Related]
37. The potential of small chemical functional groups for directing the differentiation of kidney stem cells.
Murray P; Vasilev K; Fuente Mora C; Ranghini E; Tensaout H; Rak-Raszewska A; Wilm B; Edgar D; Short RD; Kenny SE
Biochem Soc Trans; 2010 Aug; 38(4):1062-6. PubMed ID: 20659004
[TBL] [Abstract][Full Text] [Related]
38. Future perspective of induced pluripotent stem cells for diagnosis, drug screening and treatment of human diseases.
Lian Q; Chow Y; Esteban MA; Pei D; Tse HF
Thromb Haemost; 2010 Jul; 104(1):39-44. PubMed ID: 20539907
[TBL] [Abstract][Full Text] [Related]
39. Human pluripotent stem cells in drug discovery and predictive toxicology.
Laustriat D; Gide J; Peschanski M
Biochem Soc Trans; 2010 Aug; 38(4):1051-7. PubMed ID: 20659002
[TBL] [Abstract][Full Text] [Related]
40. Combining small molecules for cell reprogramming through an interatomic analysis.
Feltes BC; Bonatto D
Mol Biosyst; 2013 Nov; 9(11):2741-63. PubMed ID: 24056910
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
